highperformr logo

insitro's Overview

Total employees319
HeadquartersSouth San Francisco
Founded2018

Insitro is a data-driven drug discovery and development company that is reprogramming the way drugs are created by integrating machine learning and high-throughput biology at scale. Founded in 2018 by Daphne Koller, Insitro aims to generate predictive models of human disease and develop novel therapeutics. The company focuses on building large, high-quality datasets, deriving novel biological insights through machine learning, and translating these insights into impactful medicines for patients.

Where is insitro's Headquarters?

HQ Function

Primary hub for research and development, machine learning model creation, high-throughput biological data generation, and corporate operations.

Notable Features:

State-of-the-art laboratories equipped for high-throughput biology, automation, and 'omics data generation, alongside collaborative workspaces designed to foster innovation between computational and biological teams.

Work Culture:

A highly collaborative, science-driven, and mission-oriented environment. Emphasis on interdisciplinary teamwork, continuous learning, innovation, and leveraging data to solve complex biological problems.

HQ Significance:

Serves as the nerve center for Insitro's pioneering approach to integrating machine learning with biology, driving all strategic and operational aspects of the company's mission to transform drug discovery.

Values Reflected in HQ: The facility's design and capabilities reflect Insitro's core values of collaboration, cutting-edge science, innovation, data-driven decision-making, and a commitment to patient impact.

Location:

While Insitro's primary operations, including its advanced laboratories and computational infrastructure, are centralized in its South San Francisco headquarters, its research aims to address global health challenges. The company engages in strategic collaborations with global pharmaceutical partners (e.g., Boehringer Ingelheim, previously Bristol Myers Squibb) and leverages diverse datasets, reflecting a global outlook in its mission to discover and develop new medicines. Its investor base is also international, further underscoring its global connections and aspirations.

Street Address:

279 E Grand Ave

City:

South San Francisco

State/Province:

CA

Country:

USA

insitro's Global Presence

Buying Intent Signals for insitro

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of insitro

As of April 2025, insitro' leadership includes:

Daphne Koller, Ph.D. - Founder & Chief Executive Officer, Board Member
Martha Rook, Ph.D. - Chief Operating Officer
Philip Tagari - Chief Scientific Officer
Percy Sivam, M.B.A., C.P.A. - Chief Financial Officer
Sara Nayeem, M.D., M.B.A. - Chief Business Officer
Jevan Soo Lenox, M.Phil, M.B.A. - Chief People Officer
Eric Shiozaki, Ph.D. - SVP, Therapeutic Drug Discovery
Ellen Berg, Ph.D. - SVP, Disease Modeling
Matthew Rasmussen, Ph.D. - SVP, Data Engineering
Theofanis Karaletsos, Ph.D. - SVP, Machine Learning
Fergal Casey, Ph.D. - SVP, Neuroscience
Eilon Sharon, Ph.D. - VP, Data Science

Investors of insitro

insitro has been backed by several prominent investors over the years, including:

ARCH Venture Partners
Andreessen Horowitz (a16z)
Foresite Capital
GV (Google Ventures)
Third Rock Ventures
CPP Investments
SoftBank Vision Fund 2
T. Rowe Price
Casdin Capital
BlackRock
Coatue
Fidelity Management & Research Company LLC
General Catalyst
JS Capital LLC
Mubadala Investment Company
Temasek

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits0

Insitro has strengthened its executive leadership over the past year with key appointments in finance and business development, positioning the company for continued strategic growth and advancement of its pipeline.

New Appointments:

Percy Sivam, Percy Sivam appointed as new Chief Financial Officer.
Sara Nayeem, M.D., M.B.A., Sara Nayeem appointed as new Chief Business Officer.

Technology (Tech Stack) used by insitro

Discover the tools insitro uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

insitro Email Formats and Examples

Insitro commonly uses the email format combining the first initial of the first name with the full last name. This is a standard convention in many technology and biotechnology companies.

[first_initial][last]@insitro.com

Format

dkoller@insitro.com

Example

90%

Success rate

News and media

Insitro Press Release2024-05-21

Insitro Announces Multi-Target Drug Discovery Collaboration with Boehringer Ingelheim to Address Metabolic Diseases

Insitro and Boehringer Ingelheim entered a five-year collaboration to discover and develop new medicines for metabolic diseases, leveraging Insitro's human-centric platform. Insitro will receive an upfront payment and is eligible for milestone payments and royalties....more

Insitro Press Release2024-02-27

Insitro Appoints Sara Nayeem, M.D., M.B.A. as Chief Business Officer

Insitro announced the appointment of Sara Nayeem, M.D., M.B.A., as chief business officer (CBO). Dr. Nayeem brings extensive experience in healthcare investment, strategy, and business development to Insitro....more

Insitro Press Release2023-11-01

Insitro Appoints Percy Sivam as Chief Financial Officer

Insitro announced the appointment of Percy Sivam as chief financial officer (CFO). Mr. Sivam has a strong background in financial leadership within the biopharmaceutical industry....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including insitro, are just a search away.